Pediatrics
News
Lipids may improve with treatment of juvenile idiopathic arthritis
Major Finding: Disease inactivity after 18 months of treatment with antirheumatic drugs was associated with an increase of 5.5 mg/dL in HDL...
Commentary
Implementing Health Reform: CHIP funding extended
Conference Coverage
Combo may be best rescue therapy for resistant Kawasaki disease
Major Finding: Nonresponders to IVIG plus aspirin for treatment of acute Kawasaki disease were significantly more likely to respond to rescue...
News
Canakinumab shown effective against systemic JIA
Major Finding: After a single dose, 84% of patients who received canakinumab achieved a JIA ACR 30, compared with 10% of those who received...
News
IL-6 inhibitor tocilizumab proved effective in severe, refractory JIA
Major Finding: Significantly more patients receiving tocilizumab (85%) than receiving placebo (24%) met the primary outcome of a JIA ACR 30...
News
Treatment Does Not Explain Slightly Increased Opportunistic Infections in JIA
Major Finding: Infections that occurred at a higher rate in the JIA cohort were Coccidioides (3 infections, for an incidence rate of 21 per 100,...
News
Does an Active Childhood Build Strong Knees?
Major Finding: Childhood physical activity was significantly associated with increased tibial bone area in early adulthood, including an...
Conference Coverage
Tocilizumab Helped Kids With sJIA Catch Up on Growth
Major Finding: Height measurements at baseline in 112 children aged 2-17 years who were enrolled in the study showed profound growth failure, but...
Conference Coverage
Tocilizumab Shown to Be Efficacious in Polyarticular JIA
Major Finding: By 16 weeks, up to 93% of polyarticular juvenile idiopathic arthritis patients taking tocilizumab had achieved a JIA ACR30.Data...
Conference Coverage
Infliximab Not Cardioprotective in Kawasaki
Major Finding: Compared with placebo, infliximab reduced the erythrocyte sedimentation rate by 22% and shortened the duration of fever by 50%, but...